Navigation Links
Translate High Yields of Active Protein

ActivePro In Vitro Translation Kit


Translation products have higher biological activity than those from other E. coli lysate systems

Efficient synthesis of a wide range of prokaryotic and eukaryotic proteins

Fast translation and high protein yield

Easy to use

You really can have it all with the the ActivePro In Vitro Translation Kit--high yields, active protein, and short reaction time. Get more full-length, active protein from both prokaryotic and eukaryotic templates.


High Yields of Active Protein
There are several in vitro translation kits available commercially, but only one has it all -- high yields of biologically active protein in the shortest amount of time. The ActivePro In Vitro Translation Kit is a coupled transcription/translation system capable of expressing prokaryotic and eukaryotic sequences in 1-2 hours. It is a cell-free, scalable, simple to use kit, that is ideal for functional assays, protein interaction studies, and expression screenings. Compared to other E. coli lysate systems, ActivePro generates proteins with higher biological activity, in comparable yields.

Figure 1 compares the yield and activity of proteins expressed using the ActivePro Kit with those from two other E. coli lysate kits. The experiment includes both a prokaryotic (CAT) and a eukaryotic (GFP) protein. The data demonstrate ActivePro's superior ability to translate high yields of full-length protein with a higher level of biological activity than competitor's kits. ActivePro's ability to transcribe/translate both eukaryotic and prokaryotic templates over a broad size range is summarized in Figure 2.

Figure 1. Protein Yield, Quality, and Activity Comparison of E. coli Lysate Kits. (A) Autoradiograph of 35S-labeled GFP and CAT proteins that were in vitro transcribed/translated using Ambion's ActivePro Kit and two other commercially available kits, according to protocol. 5 l aliquots of each reaction were assessed by SDS-PAGE and phosphorimaging. (B) Aliquots from each reaction were assessed for protein activity by either measuring GFP fluorescence on a SPECTRAmax GEMINI XS Fluorometer (Molecular Devices), or using the method described by Shaw [1] to evaluate CAT activity.

Figure 2. ActivePro Transcribes/Translates Both Prokaryotic and Eukaryotic Proteins Over a Broad Size Range. (A) DNA templates (1-2 g) for several prokaryotic and eukaryotic proteins were in vitro transcribed/translated with the ActivePro Kit in reactions that included 20 Ci 35S-labeled methionine. 5 l aliquots of each reaction were assessed by SDS-PAGE and phosphorimaging. (B) Table summarizing protein yield and activity data with the ActivePro Kit. Incorporated 35S-methionine was measured by TCA precipitation and total protein yields were calculated. CAT activity was measured using methods described by Shaw [1], Rhodanese activity by the colorimetric assay described by Sorbo [2], Luciferase activity by luminescence, GFP activity by fluorescence, and -galactosidase by colorimetric ONGP hydrolysis assay


Human Protein Expression
ActivePro's versatility with a wide range of proteins is further demonstrated by the expression of human templates--Caspase3, MAPK9, and Casein Kinase. The results from expressing these human proteins using the ActivePro Kit are shown in Figure 3.

Figure 3. Complex Human Proteins are Translated With the Same Yield and Efficiency as other Types . (A) DNA templates (1-2 g) for three human proteins were in vitro transcribed/translated using 20 Ci 35S-labeled methionine for 1 hour at 37C according to the ActivePro protocol. 5 l of each reaction were assessed by SDS-PAGE gel and phosphorimaging. (B) Table summarizing data on protein expression yields (calculated as described in Figure 2).


Make the Switch Today
Whether you are currently using an E. coli or a reticulocyte lysate translation system, making the switch to Ambion's ActivePro In Vitro Translation Kit can give you higher yields of more active protein in the shortest amount of time.


back to top


Ordering Information
Cat# Product Name Size 1295 ActivePro In Vitro Translation Kit 25 rxns
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Translate High Yields of Biologically Active Proteins
2. Translate More Protein with Higher Biological Activity
3. Yeast Protein Production System Features High Yields and One-Step Purification
4. ArrayScript RT: Maximize Yields of Full-length cDNA
5. Recover High Yields of Total Nucleic Acid from Formalin-fixed, Paraffin-embedded (FFPE) Tissue
6. Synthesize High Yields of Biotinylated aRNA
7. Production of Full-Length, Biologically Active MEK1WT and MEK1CA
8. Highly Active and Removable AffinityTagged Lambda Phosphatase
9. Rapid PCR* Using Active Tube Temperature Control On Thermos PCR Machines
10. A New C-Terminal GST Vector for Protein Production in S. pombe
11. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Translate High Yields Active Protein

(Date:4/23/2015)... April 23, 2015 Delpor, Inc. (Delpor), ... that the United States Patent and Trademark Office has ... NANOPORâ„¢ technology. US Pat. No. 8,986,727 was ... drug delivery device for the sustained release ... technology for the sustained (zero-order) release of large and ...
(Date:4/22/2015)... RICHMOND, Calif. , April 22, 2015  Sangamo ... first quarter 2015 financial results and accomplishments. ... reported a consolidated net loss of $5.3 million, or ... $7.6 million, or $0.12 per share, for the same ... Company had cash, cash equivalents, marketable securities and interest ...
(Date:4/22/2015)... , April 22, 2015   MPIRICA Health ... announced $1.6M in Series A financing from the ... funding helps accelerate consumer and employer awareness of ... surgeries at over 4,800 U.S. hospitals. ... are probably very concerned about choosing the hospital ...
(Date:4/22/2015)... April 22, 2015 Steep Hill, the ... today that it has opened an investment round ... and expansion.  The common stock investment round will ... a law intended to encourage funding of small ... 506(c), small businesses largely relied on friends and ...
Breaking Biology Technology:Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 2Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its Nanopore Technology which Enables the Sustained Release of Drugs from a Small Implant Device 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8MPIRICA Health Inc. Secures $1.6M to Promote FICO-Like Quality Scores for Surgeries 2Steep Hill Launches $5M Limited Stock Offering 2Steep Hill Launches $5M Limited Stock Offering 3
... Scientists engaged in biological research and drug discovery are ... BioInformatics, LLC ( www.gene2drug.com ), the premier research ... released preliminary data from the company,s newest report ... Science Suppliers. In this report, we set out ...
... LOUIS, Feb. 11 Sigma-Aldrich, a leading Life,Science and High ... by 6% to $0.68 from $0.64 in the same quarter ... $510 million in the fourth quarter 2008 declined by 4%,compared ... fourth,quarter grew 3% from a year ago. Fourth quarter organic ...
... Development for Chronic Pain IndicationsLA JOLLA, Calif., Feb. ... TPTX ) today announced that oral administration of ... and well-tolerated in healthy male and female subjects ... successful completion of this Phase I trial demonstrating ...
Cached Biology Technology:Life Science Labs Reacting to the Economic Crisis 2Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 2Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 3Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 4Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 5Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 6Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 7Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 8Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 9Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 10Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 11Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 12Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009. 13First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 2First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 3First Multiple Dose Clinical Trial of TorreyPines Therapeutics' Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated 4
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... by the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore ... key protein linked to stem cell-like behavior in terminal-stage ... drugs that may extend the survival of these patients. ... Proceedings of the National Academy of Sciences , ...
... to reduce by more than half the time it takes ... researchers in Penn State,s College of Agricultural Sciences. The finding ... foodborne illness, allowing epidemiological investigators to identify the exact strains ... more quickly find -- and eliminate -- the source of ...
... long been used for various purposes, like cleaning wastewater at ... handcrafted wickerwork, as means of nutrition and, in traditional medicine, ... Fraunhofer Institute for Building Physics IBP in Valley now want ... to wit, for the insulation of outer walls or ...
Cached Biology News:Singapore research team identifies new drug target in deadly form of leukemia 2Researchers develop a faster method to identify Salmonella strains 2Researchers develop a faster method to identify Salmonella strains 3Using cattails for insulation 2Using cattails for insulation 3
... Kinase (PNK) catalyzes the transfer of ... 5'-hydroxyl of single- and double-stranded DNA, ... also removes the 3'-phosphate from 3'-phosphoryl ... 5'-diphosphates to form a 3'-hydroxyl group. ...
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
Request Info...
... Myeloblastosis Virus Reverse Transcriptase (AMV RT) catalyzes ... RNA or RNA:DNA hybrids (1). It requires ... than RNA primers) as well as Mg2+ ... RNase H activity. Both nonionic detergents and ...
Biology Products: